Rocket Lab Corporation has just reported earnings — the event two prior notes circled as the key test — and the stock closed at $80.04 on August 10, up 14% on the week, yet still below every price at which CEO Peter Beck was selling five weeks ago.
The insider overhang remains the defining tension in this name. Beck sold more than 1.6 million shares across July 7–8 at $81–$89, generating roughly $145 million in proceeds. Monday's close put the stock within striking distance of that range, but the gap has not closed. Net insider activity over the trailing 90 days totals approximately $302 million in net sales with no offsetting purchases — a figure that has not changed since July 8, when the last trade was recorded. Prior notes flagged this as the sharpest signal in the setup. The earnings report did not alter the arithmetic: Beck still sold meaningfully higher than the market is paying today.
The short side has been building steadily and is now the second key data point to track. Short interest climbed to 9.1% of the free float — up 18% over the past month, reaching its highest level since at least June. The week-on-week increase was modest at 2.4%, but the broader trajectory shows a position that has grown by roughly 7 million shares since early July, with no reversal. Borrow conditions, however, continue to argue against a squeeze narrative: availability is running at around 298% — meaning lenders hold nearly three shares available for every one already borrowed — and cost to borrow has eased to 0.46%, down from above 0.54% in early July. Options pricing adds no urgency either way. The put/call ratio is pinned almost exactly at its 20-day average of 0.69, with a z-score near zero, suggesting the options market absorbed the earnings event without dramatically repricing direction.
The earnings reaction itself is the one genuinely new data point this week. The most recent prior event in the history data shows a 10.7% single-day gain on August 6 — which matches the recovery arc the stock has been tracing. That print appears to have cleared enough near-term uncertainty to push the stock through $80, but the move also brought it directly back into the range where the CEO was a motivated seller. Whether that level holds or acts as resistance is the question the week's action raised without answering.
On the Street, the bull case for RKLB continues to rest on execution — Neutron vehicle development, satellite constellation expansion, and defense contract visibility. Bears note that the EV/EBITDA multiple is still running above 800x and the P/E is deeply negative, with EPS momentum ranked in the 2nd percentile over the past 30 days. The EPS surprise score is strong at the 92nd percentile — the company has a track record of beating estimates — but the valuation arithmetic requires a multi-year growth story to work. BlackRock reported adding 2.6 million shares as of July 31, bringing its position to 6.8% of shares, which provides some institutional ballast. Khosla Ventures remains the second-largest disclosed holder at 5.8%, though that filing dates to February.
The ORTEX short score has drifted higher over the past two weeks, from around 52.6 to 53.6, a modest creep rather than a sharp move, consistent with the gradual short build rather than any acute repositioning. Close peers had a strong week alongside RKLB — LUNR gained 20%, RDW surged 36%, and SATL added 35% — suggesting the week's gains were partly a sector-wide risk-on move rather than a RKLB-specific re-rating. Monday's 3.4% pullback, which RKLB shared almost symmetrically with LUNR and RDW, reinforces that read.
The stock is now trading at the lower edge of the range where its founder sold. That level — roughly $80 to $89 — is the clearest near-term marker to watch.
See the live data behind this article on ORTEX.
Open RKLB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
